Cargando…

AHNAK suppresses ovarian cancer progression through the Wnt/β-catenin signaling pathway

Globally, ovarian cancer is the 2(nd) most frequent cause of gynecologic-associated cancer fatalities among women. It has an unfavorable prognosis. There is a need to elucidate on the mechanisms involved in ovarian cancer progression and to identify novel cancer targets. We investigated and verified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yanlin, Hu, Yi, Yu, Furong, Tong, Wenjuan, Wang, Shufen, Sheng, Shunliang, Zhu, Jiayu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580348/ https://www.ncbi.nlm.nih.gov/pubmed/34689136 http://dx.doi.org/10.18632/aging.203473

Ejemplares similares

circKIF4A sponges miR-127 to promote ovarian cancer progression
por: Sheng, Shunliang, et al.
Publicado: (2020)

IC-2 Suppresses Proliferation and Induces Apoptosis of Bladder Cancer Cells via the Wnt/β-Catenin Pathway
por: Wu, Lingfeng, et al.
Publicado: (2018)

AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma
por: Zhao, Zijin, et al.
Publicado: (2017)

NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway
por: Lei, Jin-Ju, et al.
Publicado: (2015)

CK19 Promotes Ovarian Cancer Development by Impacting on Wnt/β-Catenin Pathway
por: Lu, Qi, et al.
Publicado: (2020)

MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin
por: SU, JUAN, et al.
Publicado: (2011)

Inhibition of the Wnt palmitoyltransferase porcupine suppresses cell growth and downregulates the Wnt/β-catenin pathway in gastric cancer
por: MO, MIN-LI, et al.
Publicado: (2013)

TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
por: Zhu, Linan, et al.
Publicado: (2018)

RNF43 overexpression attenuates the Wnt/β-catenin signalling pathway to suppress tumour progression in cholangiocarcinoma
por: Pangestu, Norma Sainstika, et al.
Publicado: (2021)

PDHB-AS suppresses cervical cancer progression and cisplatin resistance via inhibition on Wnt/β-catenin pathway
por: Chi, Chi, et al.
Publicado: (2023)

AHNAKs roles in physiology and malignant tumors
por: Zhang, Shusen, et al.
Publicado: (2023)

Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt/β-catenin pathway
por: Xie, Bei, et al.
Publicado: (2019)

Benzyl isothiocyanate suppresses development and metastasis of murine mammary carcinoma by regulating the Wnt/β-catenin pathway
por: Xie, Bei, et al.
Publicado: (2022)

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
por: Doo, David W., et al.
Publicado: (2020)

Phytoestrogenic molecule desmethylicaritin suppressed adipogenesis via Wnt/β-catenin signaling pathway
por: Wang, Xin-Luan, et al.
Publicado: (2013)

UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway
por: Hu, Wenjing, et al.
Publicado: (2021)

Wnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer
por: He, Kuang, et al.
Publicado: (2023)

The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway
por: Zhang, Nan, et al.
Publicado: (2023)

AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas: AHNAK2 is a biomarker for adenocarcinomas
por: Xu, Meng, et al.
Publicado: (2022)

LASP2 suppressed malignancy and Wnt/β-catenin signaling pathway activation in bladder cancer
por: Yang, Rongquan, et al.
Publicado: (2018)

Running Against the Wnt: How Wnt/β-Catenin Suppresses Adipogenesis
por: de Winter, Twan J. J., et al.
Publicado: (2021)

Silencing PPA1 inhibits human epithelial ovarian cancer metastasis by suppressing the Wnt/β-catenin signaling pathway
por: Niu, Haiying, et al.
Publicado: (2017)

BHX Inhibits the Wnt Signaling Pathway by Suppressing β-catenin Transcription in the Nucleus
por: Ding, Fengxia, et al.
Publicado: (2016)

Ahnak depletion accelerates liver regeneration by modulating the TGF-β/Smad signaling pathway
por: Yang, Insook, et al.
Publicado: (2022)

LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway
por: Song, Xue-zhen, et al.
Publicado: (2020)

Targeting ADAR1 suppresses progression and peritoneal metastasis of gastric cancer through Wnt / β-catenin pathway
por: Li, Zhiyong, et al.
Publicado: (2021)

Avasimibe Alleviates Disruption of the Airway Epithelial Barrier by Suppressing the Wnt/β-Catenin Signaling Pathway
por: Zhou, Zicong, et al.
Publicado: (2022)

The Obscure Potential of AHNAK2
por: Zardab, Mohamed, et al.
Publicado: (2022)

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2017)

FXR suppresses colorectal cancer by inhibiting the Wnt/β-catenin pathway via activation of TLE3
por: Dong, Xingchen, et al.
Publicado: (2022)

circITCH suppresses cell proliferation and metastasis through miR‐660/TFCP2 pathway in melanoma
por: Zhang, Jianfei, et al.
Publicado: (2022)

Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy
por: Lorenzon, Alessandra, et al.
Publicado: (2017)

Stratifin Promotes Hepatocellular Carcinoma Progression by Modulating the Wnt/β-Catenin Pathway
por: Ye, Shan-Ping, et al.
Publicado: (2023)

Wnt-signalling pathway in ovarian epithelial tumours: increased expression of β-catenin and GSK3β
por: Rask, K, et al.
Publicado: (2003)

LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction]
Publicado: (2023)

Andrographolide suppresses breast cancer progression by modulating tumor‐associated macrophage polarization through the Wnt/β‐catenin pathway
por: Li, Lin, et al.
Publicado: (2022)

KCTD1 Suppresses Canonical Wnt Signaling Pathway by Enhancing β-catenin Degradation
por: Li, Xinxin, et al.
Publicado: (2014)

FOXO1 inhibits osteosarcoma oncogenesis via Wnt/β-catenin pathway suppression
por: Guan, H, et al.
Publicado: (2015)

Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway
por: Roy, Sanjit K., et al.
Publicado: (2022)

Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway
por: Zhao, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_it6mu5mjb4056kbr6gqldmg5qp